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Abstract
Background: The cardiomyocyte is a prime example of inherently complex biological system with
inter- and cross-connected feedback loops in signalling, forming the basic properties of intracellular
homeostasis. Functional properties of cells and tissues have been studied e.g. with powerful tools
of genetic engineering, combined with extensive experimentation. While this approach provides
accurate information about the physiology at the endpoint, complementary methods, such as
mathematical modelling, can provide more detailed information about the processes that have lead
to the endpoint phenotype.
Results: In order to gain novel mechanistic information of the excitation-contraction coupling in
normal myocytes and to analyze sophisticated genetically engineered heart models, we have built
a mathematical model of a mouse ventricular myocyte. In addition to the fundamental components
of membrane excitation, calcium signalling and contraction, our integrated model includes the
calcium-calmodulin-dependent enzyme cascade and the regulation it imposes on the proteins
involved in excitation-contraction coupling. With the model, we investigate the effects of three
genetic modifications that interfere with calcium signalling: 1) ablation of phospholamban, 2)
disruption of the regulation of L-type calcium channels by calcium-calmodulin-dependent kinase II
(CaMK) and 3) overexpression of CaMK. We show that the key features of the experimental
phenotypes involve physiological compensatory and autoregulatory mechanisms that bring the
system to a state closer to the original wild-type phenotype in all transgenic models. A drastic
phenotype was found when the genetic modification disrupts the regulatory signalling system itself,
i.e. the CaMK overexpression model.
Conclusion:  The novel features of the presented cardiomyocyte model enable accurate
description of excitation-contraction coupling. The model is thus an applicable tool for further
studies of both normal and defective cellular physiology. We propose that integrative modelling as
in the present work is a valuable complement to experiments in understanding the causality within
complex biological systems such as cardiac myocytes.
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Background
The function of the mammalian heart depends essentially
on the properties of individual heart muscle cells, i.e. car-
diac myocytes. The complex chain of events that links
action potential (AP) with contraction, known as excita-
tion-contraction (E-C) coupling (for review see [1]), starts
with myocyte membrane depolarization followed by
opening of the voltage-gated L-type calcium channels
(LCC) during the AP. This results in a Ca2+ influx through
the sarcolemma, which activates Ca2+ release channels
(the ryanodine receptors; RyRs) located in the junctional
face of the sarcoplasmic reticulum (SR), and thereby
induces calcium release from the SR (the calcium-induced
calcium release; CICR). The resulting transient increase of
the myoplasmic [Ca2+]i allows calcium binding to pro-
teins of the contractile element that generate force and
movement by utilizing the energy stored in the high-
energy phosphate bonds of ATP. In order to avoid cumu-
lative gain of Ca2+ in the cytosol and for relaxation to
occur, SR Ca2+-ATPase (SERCA) pumps Ca2+ ions back
into the SR to be released upon the next excitation, while
the electrogenic Na+/Ca2+-exchanger (NCX) transports
part of the released Ca2+ out of the cell.
The dynamic regulation of the calcium transport mecha-
nisms is essential at varying heart beating rates. To fulfil
this task, the same cellular calcium signals that control the
contraction are also decoded by calcium-dependent
enzymes, like the Ca2+-calmodulin dependent kinases
and phosphatases. These enzymes regulate the proteins
involved in E-C coupling, providing physiologically
important feedback mechanisms [2]. Since the same
enzymes regulate nuclear gene expression during long
term alterations in the calcium signals, they thus regulate
differentiation, growth, metabolic and functional special-
izations, and eventually shape the phenotype of the mus-
cle cells during development and pathogenesis [3,4]. A
line of evidence suggests that the causes of heart failure
involve defects in the regulation of cellular calcium and a
concomitant reduction in cardiomyocyte contraction [5].
To elucidate the E-C coupling processes involved in these
pathological developments, a number of genetically engi-
neered mouse models have been generated and studied
experimentally. These models include, among others,
genetic ablation or overexpression of the E-C coupling
machinery proteins [6,7] as well as transgenic overexpres-
sion of the regulative calcium activated enzymes [8,9].
The effects genetic interventions have on the function of
the mouse E-C coupling machinery have been evaluated
on the basis of the analysis of the phenotypes of the ani-
mals bearing the genetic modifications. These analyses
have included measurements of morphological, histolog-
ical and biochemical variables from mice hearts, and also
biophysical and physiological analysis of the E-C cou-
pling at the level of individual myocytes. This approach
delivers precise data about the physiology at the endpoint,
but in order to elucidate the processes that have lead to
the endpoint phenotype it might be beneficial to use com-
plementary tools, such as mathematical modelling.
To gain more mechanistic information from the signalling
networks involved in cardiac E-C coupling and from the
sophisticated genetically engineered mouse models, we
have built a mathematical model of mouse cardiomyocyte
function. In addition to the fundamental components of
E-C coupling, contraction and membrane excitability, this
integrated model also includes the Ca2+-calmodulin-
dependent kinase II (CaMK) cascade and its modulatory
effects on the proteins involved in E-C coupling. CaMK
regulates the activity of ryanodine receptors [10], SERCA
[11] and its regulative protein PLB [12,13] and L-type
Ca2+-channels [14,15]. Because CaMK is activated by an
increase in the cytosolic [Ca2+]i and, specifically, by the
frequency of intracellular calcium transients [16,17], it
constitutes a physiological feedback mechanism adjusting
calcium signals to the current heart rate [18]. Importantly,
although the presented model is highly simplified, it is
complex enough to be robust and to have features that
arise from the signalling networks rather than from the
properties of individual components.
The developed model simulates the dynamic behaviour of
cardiomyocytes with beating frequency-dependent adap-
tations in function of the E-C coupling proteins as one of
the fundamental physiological features. It can be argued
that the model is thus an applicable and powerful tool for
the reproduction of genetic cardiomyocyte modifications
and analysis of the resulting cellular signalling changes in
silico. To establish this, we have used the model to mathe-
matically produce three different genetically modified
mouse cardiac myocytes: 1) cardiomyocytes with deleted
SERCA inhibitory protein phospholamban (PLB) [19], 2)
disruption of the CaMK-dependent regulation of LCC,
and 3) heart failure model induced by overexpression of
CaMK [20]. Our results not only reveal unexpected
changes in cardiomyocyte function upon changes of the
functions of single proteins, but also demonstrate that
mathematical modelling is an essential tool in designing
genetically modified mice models as well as exploring the
cellular signalling cascades of the existing models.
Results
Features and Validation of the Model
Our goal was to develop (see Methods section for details)
a modelling tool with which we could simulate the key
physiological aspects of the cardiac myocytes (Figure 1).
The signals that the model produces are in line with the
parameters from the experiments from mouse cardiac
myocytes. Action potential features as well as resting
potential values correspond to those reported previouslyBMC Physiology 2009, 9:16 http://www.biomedcentral.com/1472-6793/9/16
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(Table 1). Also, the model has accurate relative contribu-
tions of different calcium transport mechanisms that
cooperatively generate calcium signals with parameters
like diastolic and systolic [Ca2+]i as well as decays of cal-
cium transients corresponding to the measured average
values from various sources (Table 2). The variation
among the published experimental results is surprisingly
large (Figure 2B and 2C, and Table 2), probably due to dif-
ferences in the experimentation and treatment of the car-
diomyocytes. Therefore, it is not reasonable to tune the
model parameters exactly to any single set of experimental
results. More importantly, in order to verify the model we
focused on the physiological behaviour of the variables
and their trends during the intervention experiments. As
an example of this, the model could successfully predict
the behaviour of the experimentally observed diastolic
[21-23] and systolic [Ca2+]i around 1-4 Hz (Figure 2B). In
the experiments, a commonly used intervention to study
the capacity of the intracellular calcium stores is the caf-
feine pulse experiment, where rapid application of caf-
feine empties the SR abruptly and produces a cytosolic
calcium rise, the height of which corresponds to the
amount of calcium stored in the SR. During the caffeine
pulse, the calcium extrusion depends mainly on the NCX,
and therefore the decay of the [Ca2+]i can be used to esti-
mate the amount and activity of NCX in the given cell. We
simulated a caffeine pulse experiment and compared the
results to the in vivo data of Maier et al. [20] and Li et al.
[19]. The amplitude of the simulated caffeine-induced
intracellular calcium transient agreed well with the meas-
urements. Also the decay constants of [Ca2+]i are of the
same magnitude, 2.5 ± 0.3 s, 2.2 ± 0.2 s, and 1.8 ± 0.03 s
for [20,19] and the model simulations, respectively.
Therefore, the model fulfilled the criteria of being capable
of reproducing real physiological phenomena, like the
[Ca2+]i-frequency curve, and could robustly simulate the
caffeine pulse experiment.
To further evaluate the model features, we did a series of
simulations aimed to characterize the frequency-depend-
ent changes in the model outputs (Figure 3). Simulations
were started from a steady-state (pacing at 0.5 Hz) and the
pacing frequency was increased with six second intervals
to 1, 2, 3, and 4 Hz. These simulations demonstrate a fun-
damental feature of the E-C coupling regulation. While
the frequency-dependent changes at the level of activity of
individual proteins are small, like the change in the L-type
calcium current (Figure 3, left upper panel), the sum of
these effects is manifested as an order of greater changes
in the calcium signals. The calcium transients became
smaller as a function of pacing frequency at the same time
when the diastolic [Ca2+]i rose. This shows that even
though CaMK increases the activity of the SERCA, it can-
not fully compensate for the frequent SR calcium releases
with such a short timescale of adaptation (six second
intervals). Therefore, both the stored (network sarcoplas-
mic reticulum; NSR) and releasable (junctional SR; JSR)
pools of calcium in the SR are partially depleted, which
reduces the SR calcium release while the extra calcium
builds up the cytosolic [Ca2+]i, just like in isolated mouse
ventricular myocytes [24,25]. The rise in the diastolic
[Ca2+]i, on the other hand increases the diastolic outward
NCX current (Figure 3), which causes a small hyperpolari-
sation of the resting potential from -79.3 mV at 0.5 Hz to
-80.4 mV at 4 Hz.
As expected, the activity of both CaMK and CaN increases
with the pacing frequency from 0.5 Hz to 4 Hz. According
to the activation characteristics of CaN, its activity
increases the most at pacing frequencies from 0.5 to 2 Hz
and starts to saturate at higher frequencies (Figure 3).
CaMK, on the other hand, is activated predominantly at
frequencies higher than 2 Hz. This feature is identical to
the biphasic synaptic plasticity in neurons explained by a
model including inhibition of calcium activated CaMK
upon co-activated calcineurin [26]. The divergent fre-
quency dependence of CaMK and CaN is highlighted in
comparison of the pacing steady-state activities (Figure 4).
The difference in the ranges of CaN and CaMK activation
is even more evident, when the pacing-dependent enzyme
levels are scaled to the theoretical upper limit that can be
induced with a maximal calcium stimulus (Figure 4,
inset).
Table 1: Comparison of the AP properties of the model and experimental data
Magnitude Simulated value Experimental value
Quiescent [Na+]i (mM) 13.6 16.4 ± 0.7 [66]; 15.6 ± 0.7 [66]; 12.5 ± 1.8 [67]
Quiescent [K+]i (mM) 143.0 ~140 [81]
Quiescent EK (mV) -84.1 ~-80 [81]
Quiescent V (mV) -79.0 ~EK [81]
AP amplitude (mV) at 1 Hz 110.6 106 ± 11 [20]; 118 [68]
AP 50% duration (ms) at 1 Hz 3.25 4.5 ± 0.3 [69]; 2.6 ± 0.1 [59]; 1.6 ± 0.2 [20]
dV/dtmax (V/s) at 1 Hz 148.4 161 ± 44 (neonatal cell culture) [70]
193.25 ± 13.94 (rat) [71]; 133.8 ± 9.2 (42 days old) [58]BMC Physiology 2009, 9:16 http://www.biomedcentral.com/1472-6793/9/16
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Phospholamban Knockout Model
The elegant cardiac PLB knockout (PLB-KO) mouse
model has been used extensively to study the role of the
SR in E-C coupling [6,27,28]. One of the rare features of
the PLB-KO model among the genetically engineered car-
diac mouse models is that the PLB-KO mice do not
develop cardiac hypertrophy or failure [6]. PLB-KO can
therefore be used in the physiological elucidation of the
role of SR calcium uptake modulation via SERCA-PLB
interactions as well as the role of SR calcium uptake and
release in E-C coupling [12,29-31]. We wanted to test
whether our simulations could reproduce the experimen-
tal results of this comprehensive mouse model and reveal
possible signalling mechanisms that cannot be observed
in experiments.
Total relief of PLB inhibition of SERCA has a great impact
on the Ca2+ dynamics of the myocyte as demonstrated in
Figure 5. The simulated results of WT and PLB-KO Ca2+
transients correspond well with the wild-type and knock-
out measurements of Huser et al. [32]. The comparison of
Ca2+ transients in Figure 5A and 5B shows that the ampli-
tude ratio of PLB-KO vs. WT is 1.6 in both the in vivo and
the in silico experiments. It was previously reported that in
the PLB-KO mouse, the ventricular cardiomyocytes have a
decreased expression level of RyR [33]. We therefore
implemented this modification into the model (see Meth-
ods for details). With RyR downregulation in the model,
the amplitude of the Ca2+ transient is 12% smaller com-
pared to pure phospholamban knock-out due to a
reduced amount of calcium release units (Figure 5B). This
might indicate that the general mechanism of the com-
pensations is to attenuate the effect of initial modifica-
tions, i.e. to reduce the change in myocyte function.
As expected, the increased systolic Ca2+ concentration in
PLB-KO causes a substantial rise in the activity of CaMK
and CaN (Figure 5C). Compared to WT the mean activi-
ties of CaMK and CaN increase by 35% and 102% for PLB-
KO, and by 44% and 122% for PLB-KO* (knockout with
no compensations) at 0.5 Hz pacing. Upon an increase in
the pacing frequency, this difference becomes smaller.
Increased amplitude of the Ca2+ transient increases the
activity of SERCA both directly (increased systolic [Ca2+]i)
and indirectly (via enzymatic regulation). As a result the
decay time constants of the calcium transients decrease by
26% (PLB-KO) and 28% (PLB-KO*) compared to WT
(Figure 5D), while the Ca2+  concentration in the SR
([Ca2+]SR) increases by ~100% in both PLB-KO versions
(Figure 5E), which is in line with experimental findings
[33].
The increased CaMK activity in the PLB knockout natu-
rally affects the function of LCC as well. Surprisingly, in
the simulations the peak value of ICa, L is actually reduced
by 3% in PLB-KO vs. WT simulations for 0.5 Hz pacing.
This results from the fact that PLB-KO myocytes have
enhanced calcium release due to higher [Ca2+]SR  and
increased CaMK phosphorylation of RyR. This ≈ 2-fold
increase in Jrel brings more calcium to the vicinity of the
LCCs, thus causing a faster inactivation of the channels.
This mechanism has been observed also in experiments
[34] and explains elegantly how the complex system con-
trols itself to cope with the changed functional environ-
ment.
The overall change in the in silico PLB-KO phenotype cor-
responds very well with in vivo results and is rather
straightforward, i.e. due to the increased SERCA activity
the relaxation of the myocyte is accelerated significantly
(Figure 5D). This advantage, however, falls short com-
pared to the physiologically more relevant phenomena.
The force-frequency relation (FFR) is reversed: Δ(F4 Hz - F1
Hz) value is +43% and -20% in WT and PLB-KO simula-
tions, respectively. Frequency-dependent acceleration of
relaxation (FDAR) is also blunted in the PLB knockout
myocytes: the  0.5 Hz / 4 Hz ratio of calcium transient decay
is reduced from 3.5 to 2.3 for WT vs. PLB-KO. However,
Table 2: Comparison of Ca2+ handling properties of E-C coupling in the developed model and experiments
Magnitude Simulated value Experimental value
Diastolic [Ca2+]i (μM) 0.10 0.100 ± 0.012 [66]; 0.099 ± 0.011 [21]; 0.200 ± 0.021 [20]
Systolic [Ca2+]i (μM) 0.46 0.458 ± 0.073 [66]; 0.314 ± 0.028 [21]; 0.425 ± 0.026 [20]
Decay constant of Ca2+ transient (ms) 190 166 ± 12 (0.25 Hz) [66]; 293 ± 19 [20];
188 ± 14 (0.5 Hz) [19]; 210 (0.5 Hz) [2]
∫ICa, L dt (μM) 1.0 1.5 [22]
Maximum JREL (μmol/Lcytosol/ms) 2.2 3 (rat) [72,81]
Diastolic SR Ca2+ content (μM) 92 142 ± 9 [20]; 102 (0.5 Hz) [19]; 64.3 ± 13.0 (0.5 Hz) [73]
Fractional release (%) 28 29 ± 3 [20]
SERCA Ca2+ removal fraction (%) 89 88 [20]; 90.3 (0.5 Hz) [19]; 88 (0.5 Hz) [73]
NCX Ca2+ removal fraction (%) 10 12 [20]; 9.2 (0.5 Hz) [19]; 12 (0.5 Hz) [73]
Slow Ca2+ removal fraction (%) 0.56 0.5 (0.5 Hz) [19]
FDAR (τ1 Hz/τ4 Hz) 2.36 2.06 ± 0.08 (τ0.5 Hz/τ4 Hz) [20]; 1.87 ± 0.06 (τ1 Hz/τ5 Hz) [74]
Simulation results are shown for 1 Hz pacing steady-state. All concentrations are in cytosol volume.BMC Physiology 2009, 9:16 http://www.biomedcentral.com/1472-6793/9/16
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while the physiological adaptation to increased pacing is
impaired, the function of the myocytes is in fact
improved; the PLB-KO just recruits the contractile reserve
at lower frequencies.
Transgenic Model of CaMK-Dependent Regulation of L-
type Calcium Channel
In order to find out how the function of the cardiac myo-
cyte would change when the CaMK-dependent regulation
is switched off, we implemented a transgenic version of
the model, in which the modulation of LCC is disrupted
either by blocking the phosphorylation (bLCC) or setting
the phosphorylation site constitutively active (cLCC); see
Methods section for details of implementation. The exper-
imental results indicate that the activation of CaMK pro-
motes longer openings of the L-type calcium channels
[14]. At the level of the whole cardiomyocyte, this mani-
fests as slower inactivation and increased peak of the ICa, L
current [35]; a phenomenon referred to as "facilitation".
According to simulations, the disrupted CaMK-dependent
modulation of LCC changes the frequency-dependence of
ICa, L (Figure 6A). The maximum deviation of the ampli-
tude of ICa, L from WT is -4.3% (at 4 Hz) and +7.5% (at 0.5
Hz) for bLCC and cLCC, respectively. The contractile
force, which can be considered as a characteristic output
of the end-point phenotype, is affected only to a very
small extent (Figure 6C). The inset of Figure 6C further
indicates that the dynamics of the force are not drastically
affected. That is, the main changing variable is the ampli-
tude of the force, whereas, the baseline tension, time-to-
peak-force and relaxation time remain practically con-
stant compared to WT. As one could expect for a short
action potential animal such as the mouse, the AP dura-
tion (at 90% repolarization) is virtually unaltered
between the transgenic and wild-type models (Figure 6B).
The increased (in cLCC) and decreased (in bLCC) ICa, L
should lead to accumulation and depletion of intracellu-
lar calcium, respectively. In the simulation results, this is
seen as altered SR calcium content (Figure 6D) and conse-
quent changes in the integral of Jrel (Figure 6E). These two
parameters behave differently in function of the pacing
frequency. While the deviation of bLCC from WT is paral-
lel to the changes of ICa, L (Figure 6E), the difference
between cLCC and WT is more pronounced in the integral
of Jrel. This is due to the fact that calcium release from the
SR is affected not only by the increased SR calcium con-
tent but also by the enhanced trigger, i.e. ICa, L.
Intuitively, the changes in the calcium current should per-
haps lead to more significant changes in the E-C coupling,
since LCC is one of the main components of cellular cal-
cium transport machinery. Furthermore, the strong cou-
pling of [Ca2+]i and CaMK activation, decreased in bLCC
and increased in cLCC, should work to enhance those
alterations due to consequent changes in the phosphor-
ylation of the other CaMK targets RyR and SERCA. This
scenario is, however, affected by another regulatory loop.
In the bLCC case, decreased ICa, L leads to decreased Jrel,
Schematic presentation of the components and features of  the model Figure 1
Schematic presentation of the components and fea-
tures of the model. Model accounts for processes that 
regulate intracellular concentration changes of sodium, 
potassium and calcium ions. The Ca2+ transport mechanisms 
are the L-type Ca2+ current (ICa, L), ryanodine receptor (RyR), 
SR Ca2+ ATPase (SERCA), sarcolemmal Na+/Ca2+ exchanger 
(NCX), sarcolemmal Ca2+ ATPase (PMCA), and background 
Ca2+ current (ICa, b). The Ca2+ fluxes within the cell are the 
uptake of Ca2+ (Jup) from the cytosol to the network sarco-
plasmic reticulum (NSR), Ca2+ release (Jrel) from the junc-
tional SR (JSR), Ca2+ flux (Jtr) from the NSR to JSR, Ca2+ leak 
(Jleak) from the NSR to the cytosol, Ca2+ flux from the sub-
space (SS) volume to the bulk myoplasm (Jxfer) and from the 
cytosol to Troponin (JTRPN). The cytosolic bulk Ca2+ concen-
tration is [Ca2+]i. The calcium concentrations in the SS, JSR 
and NSR compartments are [Ca2+]SS, [Ca2+]JSR and [Ca2+]NSR, 
respectively. The Ca2+ buffers that operate in the JSR and 
related to TRPN are presented as CSQN and BUFFER, 
respectively. The input for the enzyme reactions is the intra-
cellular cytosolic Ca2+ concentration, [Ca2+]i. A rise in the 
[Ca2+]i level increases Ca2+ binding to calmodulin (CaM), 
which in turn phosphorylates more Ca2+/calmodulin-depend-
ent protein kinase II (CaMK) and calcineurin (CaN). Phos-
phorylation of the latter induces phosphorylation of protein 
phosphatase 1 (PP1). The autophosphorylation of CaMK is 
presented as a positive feedback loop and PP1 inhibition as a 
negative feedback. The model also includes the following 
transmembrane currents: the Ca2+-activated chloride (Cl-) 
current (ICl, Ca), the rapidly recovering transient outward K+ 
current (IKto, f), the slow delayed rectifier K+ current (IKs), the 
rapid delayed rectifier K+ current (IKr), the ultrarapidly acti-
vating delayed rectifier K+ current (IKur), noninactivating 
steady-state voltage activated K+ current (IKss), the time-inde-
pendent K+ current (IK1), fast Na+ current (INa), Na+ back-
ground current (INa, b), and the Na+/K+ pump (INKA).
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which reduces the calcium-dependent inactivation of
LCC; a chain of events that affects the intracellular calcium
dynamics in the opposite direction in cLCC. Thus, in both
cases this autoregulation would tend to reduce the origi-
nal effect of altered ICa, L. To demonstrate this, we calcu-
lated what the inactivation of LCC would be in the
transgenic models if all the other parameters were identi-
cal to WT (Figure 6F; dashed lines); see Methods section
for details of this acute TG. This shows that with the feed-
back systems present, the autoregulation mechanisms
bring the system closer to WT behaviour. Thus, a change
in one physiological regulatory event, in this case the dis-
rupted modulation of the LCC, cannot easily induce dras-
tic changes to the overall function of the myocyte.
CaMK Overexpression Model
CaMK has a substantial role in the E-C coupling of both
the normal and the failing heart [36-39]. Cardiac overex-
pression of the cytosolic isoform of CaMK results in car-
diac hypertrophy and a unique phenotype of the
myocytes [20]. The phenotype resulted from the initial
modification (3× increase in the CaMK expression), but
also from a variety of significant changes in the expres-
sions of E-C coupling proteins, like SERCA, RyR and NCX
[20]; see Methods for details. To elucidate the relative con-
tribution of these two mechanisms, i.e., the CaMK overex-
pression and the compensatory changes, we implemented
two versions of the in silico model. The first one
(CaMK3X) simulates the experimentally observed pheno-
Validation of the model characteristics Figure 2
Validation of the model characteristics. (A) Normalized action potential (Vm), [Ca2+]i transient and force amplitude at 1 
Hz pacing. (B) Diastolic (closed symbols) and systolic (open symbols) [Ca2+]i values as a function of pacing frequency. Simulated 
values (black squares) are compared with the experimental results of Ito et al. [21] (red circles) and Antoons et al. [57](green 
triangles). The model was able to successfully reproduce the experimentally observed minimum in the systolic [Ca2+]i around 
1-2 Hz [21]. (C) Simulated (black) action potential (AP) is compared to measurements by Guo et al. [58] (red), Brunet et al. 
[59] (green) and Petrashevskaya et al. [60] (cyan). The comparison of recorded and simulated APs (note that the APs have 
been shifted in time for comparison) demonstrates a good qualitative agreement with the experiments. (D) [Ca2+]i transient at 
1 Hz pacing. Comparison of simulated results (black) to the experimental data of Williams et al. [61] (red), Maeir et al. [20] 
(green) and Huser et al. [32] (cyan) demonstrates a good qualitative agreement of in silico and largely variated in vivo data. (E) 
Caffeine-induced [Ca2+]i transients. The amplitude and decay time constants of simulated data (black) are of the same magni-
tude with the in vivo results of Maeir et al. [20] (red) and Li et al. [19] (green).
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type and the second one (CaMK3X*) a theoretical situa-
tion, where there are no compensations at the level of
gene expression (implementation scheme can be found in
Methods).
When the total amount of CaMK was increased 3× corre-
sponding to the level of the CaMK in the CaMK-TG cardi-
omyocytes, the amount of active CaMK was changed
dramatically at any given pacing frequency in the model
(Figure 6A). At 1 Hz pacing, CaMK activities were 2.5 and
4.3 times higher than WT in the CaMK3X and the
CaMK3X*, respectively. When CaMK activity is forced to
such a high level, increased phosphorylation of CaMK tar-
gets should increase the calcium influx (via LCC), and
increase SR calcium uptake (via PLB and SERCA) and
release (via RyR), which together should increase the cal-
cium signals dramatically. Therefore the reported CaMK-
TG mouse cardiomyocyte phenotype seems counterintui-
tive, because TG myocytes have dramatically decreased
Ca2+ transient amplitudes (Figure 7B). Contrary to this,
the model predicts that CaMK overexpression alone
(CaMK3X*) increases the calcium transient amplitude by
117%, and contraction force by 126% (Figure 7C), while
the calcium transient decay (τCa) decreases simultane-
ously by 41% compared to WT at 1 Hz (Figure 7D).
At the level of cytosolic calcium signals and contraction,
these changes are qualitatively almost identical to those
induced by deletion of PLB (Figure 5B). However, while
the compensations in PLB-KO myocytes are minute and
Examples of outputs (colour coding matches Figure 1) during a dynamic in silico pacing experiment Figure 3
Examples of outputs (colour coding matches Figure 1) during a dynamic in silico pacing experiment. The simula-
tion series was started from a steady-state (pacing at 0.5 Hz) and the pacing frequency was increased with six second intervals 
to 1, 2, 3, and 4 Hz. Left panel shows the L-type calcium current (ICa, L), sodium calcium exchanger current (INCX), and calcium 
concentration in the cytosol ([Ca2+]i). Whereas the peak amplitude of ICa, L is hardly changed, the calcium transients become 
smaller as the pacing frequency increases, because the sarcoplasmic reticulum (SR) Ca2+ stores are reduced. At the same time, 
the rise of the diastolic [Ca2+]i causes an increase in the diastolic outward INCX. In the right panel, the concentration of active 
calcineurin (CaN) and Ca2+/calmodulin-dependent protein kinase II (CaMK), as well as the calcium concentration in the net-
work SR (CaJSR) and in the junctional SR (CaNSR), are presented from the same incremental simulation. The CaN curve follows 
the Ca2+ transients more closely, in fact oscillating clearly at the lowest pacing frequencies, whereas CaMK activity displays a 
stronger integrative aspect and, accordingly, a much smoother time-course.
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the phenotype is mainly due to ablation of PLB, the
CaMK-TG phenotype seems to be induced mostly by sec-
ondary changes in gene expression. That is, when the doc-
umented changes in the protein levels of CaMK-TG
myocytes were implemented into the model, the ampli-
tude of the simulated calcium transients decreased by
62% and the contraction force by 90% at 1 Hz pacing
compared to the WT model. Quite naturally the smaller
calcium signals also affect the amount of calcium acti-
vated CaMK, which is reduced by 41% compared to the
CaMK3X*. Again this demonstrates a general feature of
biological feedback loops, where secondary modifications
tend to reduce the strength of the initial stimulus. Despite
the dramatically increased CaMK phosphorylation, which
promotes activation of RyR, the amount of calcium
released from the SR is significantly smaller (55%
decrease at 1 Hz pacing) in the CaMK3X (Figure 7E). Thus,
the reduction in the [Ca2+]SR prevents an increase in cal-
cium release (Jrel). This conclusion is supported by the fact
that the fractional release is reduced by 40% from 0.28 to
0.17 in silico.
In the model with CaMK overexpression and the reported
changes in the protein levels, SR calcium content is
reduced by 25% (data not shown). However, it was
reported earlier that in vivo the reduction was 44% [20].
To explain the prominent reduction of the SR calcium
content, it was reported that the diastolic Ca2+ leak was
increased 4-fold in the TG vs. WT mice [20]. To account
for this mechanism, we updated the model with a putative
CaMK-dependent RyR leak (see Methods section for
details), which produced a ≈ 3-fold increase in the resting
Ca2+ leak for CaMK3X vs. WT (data not shown). When
simulated together with the CaMK3X model version, the
RyR leak did not induce a significant effect on the already
depressed E-C coupling. We found that the SR Ca2+ con-
tent was reduced by 17% in the leaky CaMK3X compared
to the non-leaky version, but the Ca2+ transient amplitude
and contraction force were decreased only slightly (Figure
7F and 7G). According to the simulations, the WT in silico
myocyte was not affected to a large extent by the leakiness
either.
When leaky RyRs were simulated together with the acute
effect of CaMK overexpression (CaMK3X*), calcium sig-
nalling was drastically changed. As expected, upon an
increase in the RyR leak, the SR calcium content was
decreased by 38% (at 1 Hz), leading to reduced SR cal-
cium release and subsequently smaller calcium transients
(Figure 7C). However, it is quite unexpected that accord-
ing to simulations the RyR leak might have some benefi-
cial effects on the function of cardiomyocytes facing an
acute increase in CaMK activity. While limiting the
increase in the calcium transient amplitude, the RyR leak
enhances the calcium transient decay (Figure 7D) and,
more importantly, restores the positive trend of the force-
frequency-relationship (Figure 7F and 7G). The physio-
logical adaptation to an increase in the contraction rate is
thus re-established. This data is qualitatively in line with
the results from a robust acute overexpression of CaMK in
rabbit cardiomyocytes [40]. It was reported that despite a
5- to 6-fold increase in the amount of active CaMK, the
contractility was unaltered because the CaMK-dependent
RyR phosphorylation was increased and consequently SR
Ca2+ leak was greatly augmented [40]. Our modelling
implies that in the acute overexpression state the CaMK-
dependent the RyR leak might work as a compensatory
mechanism to restore some features of E-C coupling by
limiting the effects of overly enhanced CaMK activity on
the calcium signals.
CaMK overexpression simulations also give predictions of
how the altered calcium signalling affects the activity of
other calcium-activated enzymes. For example, cal-
cineurin activity, which is a master regulator of the expres-
sion of cardiac genes [41] and can promote cardiac
hypertrophy and failure [8], is indirectly modulated by
CaMK activity. The augmented calcium signals in
CaMK3X* simulations increase the CaN activity by 69%
and conversely the blunted calcium signals in CaMK3X
simulations reduce the CaN activity by 90% at 1 Hz pac-
ing compared to WT. Interestingly, when the normal pac-
ing induced calcium changes are impaired in the CaMK3X
model, the pacing induced increase in the CaN activity
The simulated concentrations of active CaN and CaMK (col- our coding matches Figure 1) Figure 4
The simulated concentrations of active CaN and 
CaMK (colour coding matches Figure 1). The enzyme 
activities at pacing steady-state are shown in relation to the 
maximum pacing-induced value (at 4 Hz). The divergent pac-
ing dependence of calcineurin (CaN) and Ca2+/calmodulin-
dependent protein kinase II (CaMK) is demonstrated even 
more clearly in the inset, which shows the enzyme activities 
scaled to the maximum calcium-induced value.
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(from 0.5 Hz to 4 Hz) is decreased by 32% (Figure 7H).
Consequently, the CaN activity is lower even at high pac-
ing frequencies (47% reduction at 4 Hz) compared to WT.
Another interesting observation is that the putative
CaMK-induced RyR leak tends to normalize the CaN
activity in the CaMK3X* test case, i.e. the pacing induced
changes are more similar to WT. This is again an example
of a mechanism that could help a complex biological sys-
tem maintain its physiological function in spite of genetic
interventions.
Comparison of experimental data and simulated results of WT and PLB knockout Figure 5
Comparison of experimental data and simulated results of WT and PLB knockout. Results of WT, PLB knockout 
and PLB knockout without compensation are shown with black, red and green symbols, respectively. (A) and (B) Two postrest 
Ca2+ transients from experimental [32] and simulated data are shown. There is a marked similarity of the shapes of the corre-
sponding Ca2+ transients of the simulated results and the measurements, e.g., the amplitude ratio of PLB-KO vs. WT is 1.6 in 
both the in vivo and the in silico experiments. The amplitude of the Ca2+ transient is a further 12% larger in the PLB-KO* test 
case (knockout with no compensations). (C) Amount of active CaMK and CaN as a function of pacing frequency. Compared to 
WT the mean activities of CaMK and CaN increase by 35% and 102% for PLB-KO, and by 44% and 122% for PLB-KO* at 0.5 
Hz pacing. These deviations from behaviour of the WT myocyte are attenuated when the pacing frequency is increased. (D) 
Time constants of the [Ca2+]i transient decay. Measured data [19] is compared to simulated results at 0.5 Hz. The value of   is 
decreased by 26% and 28% compared to WT for the PLB-KO and PLB-KO* simulations, respectively, and by 40% in the exper-
iments of Li et al. [19]. (E) SR Ca2+ content calculated from measured data [19] and simulated results at 0.5 Hz. The increases 
of [Ca2+]SR appears to be exaggerated in silico. However, an earlier report by Chu et al. [33] showed an 86% increase of 
[Ca2+]SR in the PLB-KO mouse myocytes compared to WT. Thus, the model prediction of the SR calcium content is in good 
qualitative agreement with the experiments.
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Discussion
Our results highlight the intrinsic complexity of cardio-
myocyte E-C-coupling, which originates from the interde-
pendencies of regulatory mechanisms involving calcium
and the components regulating the membrane excitabil-
ity. Facing this complexity, experimental observations,
even clever and ingenious ones, may not be enough to
reveal the causal connection of the cellular signalling
pathways, where networks operating in parallel form feed-
back loops that control the dynamic physiological fea-
tures of the cells. These complex networks give some
fundamental and unanticipated properties to the cell
function. For example, they make the system more robust,
i.e., tolerant to change in the single part of a signalling net-
work [42]. Even more challenging task is faced when the
networks are interfered like in studies of genetically engi-
neered models. When some cellular function is disrupted
by genetic intervention, the resulting phenotype is not
Comparison of WT and transgenic LCC models Figure 6
Comparison of WT and transgenic LCC models. The results of TG models with constitutively active CaMK-dependent 
phosphorylation (cLCC) and blocked phosphorylation (bLCC) of LCC are depicted with red circles and blue triangles, respec-
tively. These are compared to simulation results of wild-type model (black squares). (A) Peak value of L-type calcium current 
(ICa, L) as a function of pacing frequency. The ICa, L peak amplitude of bLCC model deviates rather little from the WT (-4.3% at 
4 Hz). In the cLCC model, the peak value of ICa, L is larger than in the WT (+7.5% at 0.5 Hz pacing), but the deviation decreases 
as pacing frequency increases. (B) Action potential duration (90% recovery, APD90) presented as a function of pacing fre-
quency. Compared to WT, the APD90 is virtually unchanged in both TG models. (C) Contraction force amplitude as a function 
of pacing frequency. The difference in the force amplitude is also very small: -4.9% for bLCC (at 4 Hz) and +14% for cLCC (at 
0.5 Hz). Inset shows twitch force of the WT and TG model at 0.5 Hz and 4 Hz pacing frequencies. (D) and (E) SR Ca2+ content 
([Ca2+]SR) and the integral of Ca2+ release from the SR (Jrel) during one AP plotted as a function of pacing frequency. There is 
very little change in the [Ca2+]SR at low pacing frequencies. The maximum deviation from WT is seen at 4 Hz pacing: -6% and 
+5% for bLCC and cLCC, respectively. The integral of Jrel changes slightly more -9% and +7% for bLCC and cLCC, respectively. 
(F) Demonstration of the autoregulation involving ICa, L and Jrel. Dashed lines present acute transgenic situation, in which the 
LCC inactivation is calculated from the WT parameter values. Note that the time axis of the traces has been shifted for easier 
comparison.
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Comparison of experimental data and simulated results of WT and CaMK Figure 7
Comparison of experimental data and simulated results of WT and CaMK. Black (squares), red (circles) and green 
(triangles) symbols indicate WT, CaMK overexpression (CaMK3X) and CaMK overexpression with no compensations 
(CaMK3X*), respectively. The corresponding test cases without and with CaMK induced SR leak are depicted with closed sym-
bols & continuous lines and open symbols & dashed lines. (A) CaMK activity as a function of pacing frequency. The pacing-
induced (0.5 to 4 Hz) increase of CaMK activity is 35% smaller for CaMK3X vs. WT. (B) and (C) [Car+]i transient at 1 Hz. 
Compared to WT, the amplitude of the measured [20] and the simulated transient changes by -77% and -62% due to CaMK 
overexpression, respectively, and CaMK3X* by +117%. (D) Time constants of the [Ca2+]i transient decay. At 1 Hz, the combi-
nation of CaMK overexpression and compensational changes increases the time constant of measured [20] and simulated Ca2+ 
transient decay by 7.8% and 14%, respectively. Whereas, the mere overexpression (CaMK3X*) decreases  Ca by 41% compared 
to WT. (E) Peak value of SR calcium release as function of pacing frequency. WT and CaMK3X were not affected to a large 
extent by the leakiness of RyR. Whereas, in the CaMK3X* test case, the behaviour changes strikingly. (F) and (G) The ampli-
tudes of Ca2+ transient and contractile force as a function of pacing frequency. A "leaky" RyR tends to normalize the function-
ality of the CaMK3X* test case, but has little effect in WT and CaMK3X. (H) Activity of CaN as a function of pacing frequency. 
At 1 Hz pacing, CaN activity for CaMK3X is reduced to 10% of the WT value and increased by 69% for CaMK3X*. Increased 
pacing is unable restore CaN of CaMK3X to the WT level, whereas the deviation of CaMK3X* from WT is reversed by faster 
pacing. Interestingly, the RyR leakiness brings the CaN-frequency curve of CaMK3X* closer to WT.
1234
0
2
4
6
1234
0,0
0,3
0,6
0,9
1234
0
1
2
3
1234
0,0
0,3
0,6
0,9
1234
0
15
30
45
0
100
200
300
250 ms
Pacing Frequency (Hz)
AB C
Pacing Frequency (Hz)
F
E
measured simulated
2+ Simulated Ca  Transient
(
μ
M
)
2
(
m
N
/
m
m
)
(
μ
M
)
(
μ
M
)
2+ Measured Ca  Transient
t
 
(
m
s
)
C
a
P
e
a
k
 
J
 
(
μ
M
/
s
)
r
e
l
C
a
M
K
3
X
*
C
a
M
K
3
X
W
T
C
a
M
K
3
X
W
T
CaMK3X*
WT
CaMK3X
0
,
3
 
μ
M
CaMK 3X
Pacing Frequency (Hz)
Pacing Frequency (Hz)
250 ms
0
,
3
 
μ
M
RyR leak
D
GH
Pacing Frequency (Hz)
C
a
M
K
3
X
*
C
a
M
K
3
X
W
T
2+ Amplitude of Ca  Transient Amplitude of Twitch Force Calcineurin Activity
CaMKII ActivityBMC Physiology 2009, 9:16 http://www.biomedcentral.com/1472-6793/9/16
Page 12 of 20
(page number not for citation purposes)
necessarily exactly what was expected. Instead, homeo-
static regulatory mechanisms in cells tend to minimize the
effects of the mutation on the phenotype.
The presented model is the first mathematical model of
mouse ventricular myocyte E-C coupling that also
includes the regulation of the calcium transport machin-
ery through the activation of CaMK. The model has prop-
erties common to complex biological systems, which
explain the basic features of cardiomyocyte function: 1)
pacing-induced changes in calcium dynamics via CaMK-
dependent regulation, as well as 2) robustness against
experimental interventions (caffeine-induced calcium
release) and genetic modifications (PLBKO and disrup-
tion of CaMK-dependent modulation of LCC). The simu-
lations with the model give fundamental information on
interrelations between different signalling pathways in
cardiomyocyte E-C coupling and clarify the role of parallel
feedback loops in maintaining the operation of cardiomy-
ocyte E-C coupling. We showed that through the feedback
loops cardiomyocytes are surprisingly resistant to altera-
tions in the activity of single endpoint components in the
signalling networks, whereas interventions disrupting the
feedback loops will compromise the function. According
to our simulations, these inherited properties of cardio-
myocyte E-C coupling are likely to define the impact of
genetic manipulations on the end-phenotype of the cardi-
omyocytes.
Limitations of the Study
The fundamental challenge in developing an E-C coupling
model is the rather large variability of experimental data.
Therefore, it would be an irrelevant and futile effort to try
to fit the behaviour of the model perfectly to one single set
of in vivo data. Instead, it is more essential that the outputs
of the model agree qualitatively with the majority of the
measured results, as is the case with the three fundamental
outputs (AP, Ca2+ transient and force) in our model. Fur-
thermore, the model was also able to simulate faithfully
such multivariable cellular phenomena as the force-fre-
quency relationships and the caffeine pulse experiments.
This kind of high-level validation is crucial for a model
that is comprised of multitude of submodels, because for
most of the model parameters there is no corresponding
measurement data, to which the parameter values could
be directly fitted; a second fundamental challenge in this
modelling field.
The isoform-specific differences of the CaMK reaction
chain in the neuronal vs. cardiac tissue warrant further
studies. However, a fair assumption, one that we have
made, is that these isoforms of the kinase behave in a
rather similar manner, since they share 89-93% sequence
similarity in their catalytic and autoregulatory domains
[43]. This issue was recently studied by Chiba et al. with a
mathematical model that included the CaMK-CaM inter-
action dynamics specific to neurons and cardiomyocytes
[44]. Our approach to describe this isoform divergence is,
albeit non-mechanistic, a coherent one (see Methods sec-
tion for details). The results of Chiba et al. [44] and Sau-
cerman et al. [45] also underline the significant role of
PP1 activity in CaMK dynamics. In addition to PP1, the
enzyme reaction network of Bhalla and Iyengar [46]
includes also the other two main phosphatases, CaN and
PP2A, found in cardiac myocytes. Thus, it is a comprehen-
sive description of enzyme kinetics with notable applica-
tion potential in future studies as well.
Despite the limitations mentioned above, our model
reproduces faithfully the main features E-C coupling of
mouse ventricular myocytes. Simulation results also sug-
gest that, despite or because of the complexity of the
model, it behaves robustly enough to be a suitable and
valid platform to study the physiological and pathophys-
iological phenomena in mouse cardiac myocytes. Espe-
cially interesting issue that can be targeted with our model
is the role of CaMK in various heart failure conditions.
Physiological Role of CaMK in Cardiomyocytes
CaMK is a multifunctional holoenzyme that has modu-
lates E-C coupling by phosphorylating SERCA, PLB, RyR
and LCC [14,40,47,48]. CaMK goes through a process of
autophosphorylation, i.e. the phosphorylated state con-
tinues even after the Ca2+-CaM complex has been
removed, which leads to prolonged activation of CaMK
[49]. It has been shown that the enzyme can decode the
frequency and the amplitude of Ca2+ spikes into distinct
levels of kinase activity [16]. With this unique combina-
tion of features CaMK mediates the beating frequency-
dependent regulation in cardiac myocytes and establishes
a feedback signalling network that controls cardiomyo-
cyte Ca2+ signals and excitability. Apart from this physio-
logical function, CaMK has been verified as a
proarrhythmic signalling molecule and may therefore
offer novel solutions for antiarrhythmic therapy [35,50].
In this study, we focused on the CaMK-dependent regula-
tion of E-C coupling. The presented mathematical model
was validated both in WT and transgenic test cases. Thus,
it forms a good base for further studies of the role of
CaMK, and CaN, e.g. in arrhythmia and excitation-tran-
scription coupling.
Phospholamban Knockout Model
The phospholamban knockout model is one of the few
reported mouse models, where genetic manipulation pro-
duces enhancement of the cardiac function instead of
pathological developments and failure. In theory, the
absence of PLB-dependent inhibition of SERCA should
increase the SR calcium uptake, which would result in
faster decay of calcium transients, elevated [Ca2+]SR and aBMC Physiology 2009, 9:16 http://www.biomedcentral.com/1472-6793/9/16
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subsequent increases in the amplitudes of the calcium
transients. The analysis of the PLB-KO mice showed that
all of the expected changes were present in the PLB-KO
cardiac myocytes and that the PLB ablation had induced
only very mild phenotypical compensations [19,33]. In
our model, the experimental results from the PLB-KO
mouse were mostly reproduced by ablation of the PLB,
and the reported compensatory reduction of the RyR
expression did not significantly change the E-C coupling.
The enhanced systolic [Ca2+]i also activates both of the cal-
cium-dependent enzymes in the model. Because CaMK is
predominantly activated at relatively high frequencies
(Figure 4), increase of the amplitude of calcium transient
at low frequencies elevates CaMK activity only modestly
(35% at 0.5 Hz) compared to calcineurin activity, which
is doubled at low frequency (102% increase at 0.5 Hz pac-
ing). Since calcineurin regulates cardiac gene expression
[41] and promotes cardiac hypertrophy and even failure
[8], enhanced calcineurin activity should have a great
impact on the cardiac phenotype. However, according to
the simulations presented here, at higher frequencies both
the CaMK and CaN activities of PLB-KO myocytes are nor-
malized. At 4 Hz, the enzyme activities of PLB-KO and WT
myocytes are identical, suggesting that at normal mouse
heart rates (5-10 Hz) CaMK and CaN are not changed in
PLB-KO hearts.
From the physiological point of view, ablation of PLB
causes the myocyte to recruit more calcium-activated force
than would be required at low pacing frequencies. This
change alone increases the energy consumption of the
myocyte, since the contractile element and SERCA are the
main energy consuming components of the system.
Therefore it is a surprise that the cardiac phenotype of the
PLB-KO mouse is so close to the WT and without patho-
logical changes; a finding that has been shown to endure
even in the long-term [51].
Transgenic Model of CaMK-Dependent Regulation of L-
type Calcium Channel
Considering the fundamental role that ICa, L has in E-C
coupling as the initiator of the CICR process, the enzy-
matic regulation of LCCs is an extremely interesting sub-
ject for in silico studies. The CaMK-dependent facilitation
of ICa, L is considered to be an important part of the phys-
iological regulation of E-C coupling (for review see [52])
but it may also be involved in arrhythmias [36].
Despite the crucial role of ICa, L, its CaMK-dependent reg-
ulation appears to be less essential for the regulation of E-
C coupling in mouse ventricular myocytes. In both cases,
bLCC and cLCC, with disrupted CaMK-dependent modu-
lation the autoregulatory link between ICa, L and Jrel tends
to reduce the original effect of altered ICa, L, thus bringing
the TG system closer to WT behaviour. This is a good
example of how difficult it is to combine a holistic point
of view based on the data from experimental findings. For
example, it has been reported that the super-maximal
change of ICa, L induced by the 5-6 fold overexpression of
CaMK is 22% of the calcium current [40]. If we accept that
this effect is significantly higher than the modulation
induced by maximally activated endogenous CaMK,
which would occur at the highest cardiomyocyte beating
rates (mouse ~10 Hz), then the CaMK-induced modula-
tion of ICa, L at pacing rates applicable to isolated mouse
cardiomyocytes (0.5-2 Hz) would be minute. In addition,
in experiments all other normal cellular feedback systems
controlling ICa, L will be excluded, which further biases
evaluation of the potential impact of the CaMK modula-
tion on the ICa, L and especially on the function of the
whole cell. This was well demonstrated by the model,
where the large CaMK facilitation could be expected to
produce a large modification of E-C coupling, but in silico
the effect turned out to be rather small.
CaMK Overexpression Model
To study the possible role of CaMK activity in the develop-
ment of hypertrophy and failure, a mouse model overex-
pressing cytosolic CaMK was generated by Maier et al.
[20]. This genetic intervention results in unique changes
in cardiomyocyte calcium signalling, cardiac hypertrophy
and dilated heart failure [20], suggesting that chronic
CaMK overexpression triggers drastic alteration in cardio-
myocyte gene expression.
In our model, an increase in the amount of CaMK has dra-
matic effects on myocyte function through an increase in
the CaMK activity and subsequent activation of CaMK tar-
gets. This leads to greatly augmented calcium release and
uptake resulting in enhanced calcium signals. These are
quite the opposite to the reported phenotype of the CaMK
overexpression mouse, suggesting that the compensatory
changes in the gene expression have more impact on the
CaMK-TG phenotype than the CaMK-dependent regula-
tive mechanisms per se. Supporting this, when the protein
expression changes of the CaMK-TG myocytes reported in
[20] were incorporated into the model, our simulations
produced blunted calcium signals, impaired force-fre-
quency and calcium-frequency relations, just like in the
experiments with CaMK-TG myocytes [20].
In order to understand the sequence of events leading to
the endpoint phenotype, the acute effect of the genetic
modification should be explored. Acute effects of CaMK
were studied recently by adenoviral overexpression (5- to
6-fold) of CaMK in isolated rabbit cardiomyocytes [40].
Surprisingly, CaMK overexpressing myocytes had normal
calcium transient amplitudes and reduced SR calcium
content [40]. To explain this it was suggested that the
CaMK-induced RyR phosphorylation would increase the
SR calcium leak, which in turn would reduce SR calciumBMC Physiology 2009, 9:16 http://www.biomedcentral.com/1472-6793/9/16
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load despite the CaMK-dependent increase in the SR cal-
cium uptake [20,40]. In our simulations, the CaMK-
induced RyR leak during CaMK overexpression
(CaMK3X* test case) reduced the SR calcium content and
release, in line with the experimental findings [20,40].
This leads to secondary effects: 1) due to smaller calcium
transients compared to CaMK overexpression without the
RyR leak, the amount of active CaMK and CaN are
reduced and 2) the negative trend of the force-frequency
relation is almost reversed. Thus, it would seem that in the
acute phase of the overexpression state the CaMK-depend-
ent RyR leak might be beneficial for the myocyte function,
since it acts to limit the overly enhanced calcium signals.
Due to the CaMK-induced RyR calcium leak, the initial
change of the CaMK overexpression in the calcium signals
is modest.
Why then does CaMK overexpression induce such exten-
sive compensations at the level of transcription? CaMK
overexpression differs fundamentally from PLB-KO in
that it switches off the whole physiological feedback sys-
tem between the cytosolic calcium signals and the CaMK.
Therefore, it is likely that these sorts of manipulations,
which destroy the ability of the cell to adapt to the func-
tional demands, will trigger profound transcriptional
compensations.
Conclusion
Mathematical modelling can be exploited as an integra-
tive tool to dissect the underlying processes of cellular
function in both physiological and pathophysiological
situations. The potential of in silico studies lays in the abil-
ity to simultaneously observe multiple variables and to
estimate such outputs that cannot be measured in the
experiments. Our simulations show that modelling ena-
bles conclusions about the causalities between myocyte
signalling cascades, which would be challenging to reach
solely by interpretation and analysis of in vivo measure-
ments. Thus, it is possible to gain more information of the
'autoregulatory' phenomenon in the cardiac myocyte. In
the present study, we have demonstrated this for normal
and three transgenic cell types.
Methods
We base our model of ventricular myocytes of adult
mouse on three existing model components: 1) a model
of cardiomyocyte electrophysiology by Bondarenko et al.
[53], 2) a description of the contractile element by Cor-
tassa et al. [54] and 3) a biochemical scheme of CaMK
activation by Bhalla and Iyengar [46]. A schematic draw-
ing of the developed model is presented in Figure 1.
The model parameters were adjusted, whenever possible,
according to experimental data (as specified in Tables 1, 2,
3 &4[55-75] or in the following sub-chapters) that was
either retrieved directly from literature as numerical val-
ues or digitized from visualised data. The parameter val-
ues were estimated by direct adapting from literature (e.g.,
the Km value of SERCA) or indirect fitting (e.g., for maxi-
mum pump rate of SERCA based on the decay of Ca2+
transient); see Table 3 for a complete list of modified
parameters. In either case, the fit was considered satisfac-
tory when the values and the curves of the fits were within
the standard error of the mean of the experimental values;
see Table 2. In line with most common experimental set-
tings, the model is nominally adjusted for a room temper-
ature of 25°C.
Model of Cardiomyocyte Electrophysiology
Due to the employment of a non-conservative stimulus
current, the original mouse cardiomyocyte model by
Bondarenko et al. [53] had serious stability issues that
manifested as a chronic fluctuation of intracellular [K+]
and [Na+]; see Figure 8A. To increase the pacing steady
state stability of the model, we implemented a conserva-
tive stimulation scheme, in which the stimulus current is
carried by K+ ions as suggested by Hund et al. [76]. This
approach assured that the simulation results could indeed
be obtained at a pacing steady state.
We have also made some modifications to the features
and parameters of the Bondarenko model to obtain a bet-
ter fit to the physiological data of mouse myocytes. A
comprehensive improvement was the adjustment of cal-
cium removal fractions of SERCA, NCX and plasma mem-
brane Ca2+ ATPase (PMCA). The original set of parameters
caused an imbalance between NCX and PMCA; see Figure
8B and Table 2. The modifications are described in detail
in the following subchapters; see also Table 3.
CaMK Reaction Scheme
The CaMK part of the model is based on a previously pub-
lished reaction scheme [46]. Information on the detailed
structure of the reaction pathways, parameter values and
computer source codes are available in the DOCQS Data-
base [77]. The model of the CaMK reaction chain was
originally designed for neurons, but its applicability for
cardiac myocytes has already been documented in our
previous studies [41]. Original values were used for reac-
tion rate constants, but initial concentrations of some var-
iables have been adjusted to the physiology of cardiac
myocytes (see Table 4 for details). Essentially, the CaMK
reaction scheme published by Bhalla et al. [46] is a highly
detailed mathematical description (45 differential equa-
tions) based on extensive biochemical studies, thus, it
offers novel possibilities for studying the regulation of E-
C coupling in a way not possible for example with the
simplified (one differential equation) scheme introduced
by Hund et al. [78]. A good example of this potential is the
overexpression of CaMK that is investigated in this paper.BMC Physiology 2009, 9:16 http://www.biomedcentral.com/1472-6793/9/16
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In Figure 1, the CaMK submodel is presented as a simpli-
fied control diagram. A rise in the [Ca2+]i level increases
Ca2+ binding to CaM, which in turn phosphorylates more
CaMK and CaN. Phosphorylation of the latter induces
phosphorylation of protein phosphatase 1 (PP1). The
autophosphorylation of CaMK is presented as a positive
feedback loop and PP1 inhibition as negative feedback.
The input for the enzyme reactions is [Ca2+]i upscaled by
a factor of two. This is a non-mechanistic approach; how-
ever, it emulates the higher sensitivity of cardiac vs. neu-
ronal CaMK isoform to [Ca2+], which was studied in detail
by Chiba et al. in their recent work [44]. They reported
that the calcium concentration value of half-maximal acti-
vation of CaMK autophosphorylation is ~2.5 μM and ~1.2
μM for the neuronal and cardiac isoform, respectively.
Thus, the scaling factor of two matches well to the find-
ings. It is also in line with the assumption that CaMK is
located in such calcium signalling sub-domains, in which
calcium concentration reaches, on average, higher peak
values than in the bulk cytosolic compartment.
The regulatory effect that CaMK has on SERCA, PLB, LCC
and RyR is calculated from the level of active CaMK in the
cytosol with the following equation
where the half maximal CaMK activity, Km, CaMK = 1.2 μM
and n = 3. We tested a variety of values for these two
parameters and the best fit to experimental data of the fre-
quency-dependence of the intracellular calcium dynamics
(see Figure 2B), and FDAR (see Table 2) was obtained
with these values.
The effect of CaMK-dependent regulation of calcium
transport mechanisms is demonstrated in Figure 8C. The
two sets of traces refer to simulations run with either a
normal model scheme (wild-type; black) or a scheme, in
which the CaMK activity has been "clamped" to the quies-
CaMK
CaMKactive
n
KmC a M K
n CaMKactive
n reg =
+ ,
, (2)
Table 3: Modified parameter values of the previously published model components
Symbol Description Criteria for Modification Value
GNa Maximum conductance of fast Na+ current (mS/μF) Increasing dV/dtmax of Vm 14.5
Maximum Ca2+ transport rate of PMCA (pA/pF) Adjusting Ca2+ circulation fraction 0.05
GCab Conductance of background Ca2+ current (mS/μF) Adjusting SR calcium content 3.4 × 10-4
Maximum conductance of NKA (pA/pF) Matching to recent data of ref. [67] 1.4
Km, Nai Half maximal [Na+]i sensitive activation (mM) (same as above) 18.6
nNKA Exponent of NKA Hill equation (same as above) 3.2
Ca2+ on-rate for troponin high-affinity sites (μM-1ms-1) Adapted from ref. [81] 2.37 × 10-3
Ca2+ off-rate for troponin high-affinity sites (ms-1) (same as above) 3.2 × 10-5
Ca2+ on-rate for troponin low-affinity sites (μM-1ms-1) Lowering of the baseline tension according 
to data of [21,22]
0.07
SL Sarcomere length (μm) Adapted from ref. [22] 2.0
f Scaling factor for the speed of contraction generation'(see eq. A111 in ref.) Matching the force transient to data of 
refs. [21,22]
2.3
Scaling factor for the half maximal transition rate of tropomyosin from 
permissive to nonpermissive (see eq. A112 and A113 in ref.)
(same as above) 2.8
IPMCA
max
INKA
max
khtrpn
+
khtrpn
−
kltrpn
+
f
trpn
12 /
Table 4: Initial conditions for the differential parameters
Parameter Description Value (μM) Refs.
CaM Calmodulin 6[ 7 5 ]
CaMK Basal activity of Ca2+/Calmodulin-dependent Kinase 10* [17]
total_CaMK Total amount of Ca2+/Calmodulin-dependent Kinase (buffered) 10* [17]
CaNAB_Ca2 Calcineurin with two Ca2+-sites occupied 1 [46]
I1 Unphosphorylated form of Protein Phosphatase Inhibitor-1 1.8 [46]
I1_x Phosphorylated form of Protein Phosphatase Inhibitor-1 0.001 [46]
PP1_active Phosphorylated form of Protein Phosphatase 1 1.8 [46]
tot_PP1 Total concentration of Protein Phosphatase 2A 1.8 [17]
PP2A Phosphorylated form of Protein Phosphatase 2A 0.12 [46]
PKA_active Phosphorylated form of Protein Kinase A (buffered) 0.014735 [17]
--- Parameters of the action potential model. --- [53]
--- Parameters of the contraction model. --- [54]
* A simplified approach to represent the 10 subunits, when CaMK concentration is 1 μM.BMC Physiology 2009, 9:16 http://www.biomedcentral.com/1472-6793/9/16
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cent level (CaMK inhibition; red). As the comparison with
Figure 2B demonstrates, inclusion of the CaMK-depend-
ent regulation of the calcium transport mechanisms is
essential for the positive dependence of calcium transient
amplitude on the pacing frequency. The regulation also
limits the excess rise of diastolic calcium.
Sarcoplasmic Reticulum Ca2+ ATPase
The Ca2+ uptake to SR, i.e. the flux Jup driven by SERCA, is
described with an equation that was originally formulated
by Jafri et al. [79]. In our model, we modified that equa-
tion by using the same principles that Hund et al. used in
their model of canine myocytes [78]. Parameters defining
the direct CaMK modulation of SERCA as well as the indi-
rect modulation via PLB are included in the equation
The maximal relative change in the uptake rate that CaMK
can induce,  , was set to 70% according to the exper-
imental findings of Toyofuku et al. [47]. Whether CaMK
increases Ca2+ uptake by SERCA or not has been a contro-
versial issue according experimental findings. Both an
increase [47] and a null-effect [80] have been reported.
However, more recent in vivo experimental results support
the positive effect of CaMK. Phosphorylation of PLB by
CaMK relieves its inhibitory effect on SERCA. After testing
a variety of values, we set the maximal change in the Km,
PLB value to 0.17 μM, which is consistent with the experi-
mental results of Odermatt et al. [80].
In addition to implementation of the CaMK dependence,
we also decreased the value of Vmax to 0.16 μM/ms. This
was done to increase the decay time constant of the Ca2+
transient, to correct the Ca2+ recirculation fractions of
SERCA, NCX and PMCA, and to lower the SR Ca2+ content
to a more physiological level (Table 2). Based on a wide-
ranging iteration of the apparent Km value of SERCA, we
decreased Km, up to 0.33 μM and the exponent n to 1.8.
These values gave the best overall fit to experimental data
available on SERCA and they also corresponded well to
the values suggested for all species [81]. The Km, up value is
somewhat higher than the values 0.23 ± 0.04 μM and 0.20
± 0.04 μM measured from mouse myocytes by Frank et al.
[29], but this difference is reduced by CaMK regulation.
L-Type Calcium Channel
Dzhura et al. have shown that in single channel measure-
ments CaMK promotes longer openings of LCC, i.e. gating
mode 2 [14]. At whole cell level, this is seen as slowed
inactivation [82]. Thus, in a deterministic modelling set-
ting the latter mechanisms is a feasible way to represent
the CaMK-dependent modulation. Based on experimental
results we made the γ parameter in the Markov model (see
Figure 4 in ref. [53]) dependent on CaMK regulation
according to equation (4). Parameter Kpc, max defines the
maximum time constant for Ca2+ -induced inactivation
and Kpc, half the corresponding half-saturation level. The
CaMK modulation of parameter   thus slows down the
inactivation of LCC.
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Stability of the model and characteristics of the CaMK-dependent calcium dynamics Figure 8
Stability of the model and characteristics of the CaMK-dependent calcium dynamics. (A) Intracellular Na+ and K+ 
concentrations drift during a normal pacing stimulation at 1 Hz with the original Bondarenko model [53] and the model actually 
never stabilizes to physiological steady-state. Table 1 shows the corresponding values obtained with the developed model. (B) 
In the original Bondarenko model the removal fractions of NCX and PMCA were distorted reversely; see also Table 2. (C) 
Inclusion of the CaMK-dependent regulation of the calcium transport mechanisms enhances the positive dependence of systo-
lic calcium (open symbols) on the pacing frequency. It also limits the excess rise of diastolic calcium (closed symbols) with high 
pacing frequencies, in line with the experimental findings (see Figure 2B).
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Some experiments indicate that ICa, L can be increased by
CaMK modulation as much as 40% to 50% [83,84]. How-
ever, in light of the most recent experimental results, the
modulatory effect may be smaller. Gao et al. reported that
the widely used CaMK inhibitor KN-93 has a CaMK-inde-
pendent inhibitory effect on LCC [85]. They found that
the inhibitory effect of a specific inhibitory peptide was
less than one third of the inhibitory effect that KN-93 had
on LCC [85]. Peptide inhibition studies done with rabbit
cardiac myocytes acutely overexpressing CaMK also indi-
cate a lesser modulatory increase of about 22% [40].
Based on these experimental data, we set the modulation
of parameter    so that the maximal CaMK-dependent
increase in ICa, L amplitude is ~10%.
Ryanodine Receptor Calcium Channel
Until recently, the effect of CaMK regulation on RyR (i.e.
Ca2+ release from the SR) has been a controversial issue.
While some studies have shown that CaMK decreases Jrel
[86], other studies have reported the opposite result [20].
More recent experimental results [40] and modelling
analysis [62], however, strongly support the latter hypoth-
esis. Studies with RyRs incorporated into planar lipid
bilayers suggest that CaMK phosphorylation of RyR
increases the sensitivity of release to Ca2+  and thus
increases RyR open probability [63]. We implemented
CaMK modulation of the RyR in an analogous way to
LCC. That is, we made parameter  , which defines the
Ca2+ dependent transition rate from open state 1 to open
state 2 (see Figure 1 in the original publication of Keizer
et al. [64]), CaMK-dependent as described by the below
equation.
This mechanism increases RyR open probability as a func-
tion of increasing CaMK activity. The maximal CaMK-
dependent increase of Jrel was set to ~10%.
The Transgenic Myocyte Models
In this study, we evaluate three transgenic models: 1) the
PLB knockout, 2) the disrupted CaMK-dependent modu-
lation of LCC, and 3) the model of three-time overexpres-
sion of CaMK. To carry out the first test case we
implemented two versions of the model according to the
work by Li et al. [19]. Both of them lack the PLB inhibition
of SERCA, i.e. we set value of parameter CaMK_reg to 1 in
the denominator of equation (3). In addition to this, the
first version also has a reduced RyR expression level (by
25%) as reported by Chu et al. [33]. The second version
describes a theoretical situation, where there are no such
compensations. We refer to these two model versions in
the text as "PLB-KO" and "PLB-KO*", respectively.
The two versions of the second test case were imple-
mented by setting the value of parameter CaMK_reg in
equation (4) either to 0 or 1. That is, the first version of
this model refers to a knock-out of CaMK-dependent
phosphorylation of LCC and the second version to a con-
stitutively active CaMK phosphorylation of LCC. These
transgenic models have not been studied experimentally;
instead they have been formulated according to the work
of Grueter et al. [65] and Wu et al. [87], respectively. We
refer to these two model versions in the text as "bLCC"
and "cLCC", respectively. For the study of auto-regulatory
link between LCC and RyR, we also estimated how the L-
type calcium current changes in an acute disruption of the
CaMK-dependent regulation of LCC. That is, we calcu-
lated what the ICa, L would be if everything else remained
normal. These simulations thus correspond to "WT
clamp" protocol that cannot be reproduced in vivo.
The third test case demonstrates the effects of threefold
overexpression of CaMK corresponding to the transgenic
mouse model of heart failure developed by Maier et al.
[20]. We implemented the overexpression by increasing
the total values of CaMK concentrations from 10 μM to 30
μM (see Table 4 for details). Furthermore, we made a sec-
ond model version of this test case that includes also the
compensatory changes reported by Maier et al. [20]. That
is, we changed the expression levels of SERCA, RyR and
NCX to 68%, 42% and 210%, respectively, compared to
WT, and we also reduced the SERCA/PLB ratio by 17%
[20]. These two model versions are referred in the text as
"CaMK3X*" and "CaMK3X", respectively. Additionally,
we implemented parallel versions of the three test cases
that include the putative CaMK induced diastolic SR leak
according to the following equation:
This description of the leak sets, for example in the
CaMK3X test case, about half a percent of the RyR chan-
nels to a constantly open state during diastole at 1 Hz pac-
ing.
Simulation Protocols
The presented mathematical model is a set of 91 ordinary
differential equations (ODEs). It was implemented to the
Matlab™ environment of technical programming. Simula-
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tion results were obtained by numerically integrating the
model equations with a stiff ODE solver method
(ode15s). Unless stated otherwise, all the presented
results are steady state results that were obtained by letting
simulations run as long as was needed for the model to
reach a pacing steady state. The normal stimulus that we
used was a current pulse (amplitude -80 pA/pF and length
0.5 ms) that was repeated according to the pacing fre-
quency.
The caffeine pulse experiment was executed in silico by set-
ting SERCA closed and RyR constantly open. The open
probability was set to 0.25 instead of 1 to reflect the fact
that in experiments the application of caffeine does not
result in simultaneous and infinitely fast opening of RyR
channels. The Ca2+ released from the SR is thus extruded
from the cell mainly by NCX and secondly by PMCA (see
Figure 2E).
Sodium-Calcium Exchanger
The description of the NCX current (INCX) in the Bondar-
enko model [53] is based on a combined chemical reac-
tion and free-energy barrier model developed by Luo and
Rudy [55].
Bondarenko et al. used the cytosolic [Ca2+]i value in the
fourth term of the equation. However, we modified the
equation according to previous models [56,78], i.e., we
upscaled the [Ca2+]i with a constant fNCX. This simulates
the higher sub-sarcolemmal [Ca2+]. After iteration, we
obtained the best physiological fit when the fNCX value
was set to 2. To adjust the Ca2+ recirculation fraction to a
physiological level (see Table 2), we reduced the scaling
factor for the total current kNCX to 125 pA/pF.
Contractile Element
The contractile element of the model is based on the E-C
coupling model published by Cortassa et al. [54]. That is,
we implemented equations A81 and A96-121 to our
model. Since the Cortassa model is based on guinea pig
data, we adjusted some of the parameters related to the
myofilament Ca2+ sensitivity to obtain Ca2+ transient and
contraction force characteristics (force at diastolic [Ca2+],
maximum amplitude of the force, and time-to-peak of the
force) that are typical for mouse cardiac myocytes [21,22].
Parameter modifications are presented in Table 3.
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